The enemies among us: Dr Scott Gottlieb's role in creating new intelligence office

Dr. Scott Gottlieb was appointed FDA commissioner by President Trump at age 44, and served in that role from 2017 to 2019, after which he resigned to spend more time with his family. He is a contributor to the cable financial news network CNBC, and a frequent guest on the CBS News program Face the Nation. He is also an elected member of the National Academy of Medicine.

Advertisement

He is currently a senior fellow at the American Enterprise Institute, a special partner with the venture capital firm New Enterprise Associates (NEA) and serves on the boards of Pfizer, Illumina, Aetion, and Tempus. NEA is one of the world’s largest venture capital firms. Contrary to various rumors, Dr. Gottlieb is not related to the notorious CIA leader of MK ULTRA (“Dr. Strangelove”) Dr. Sidney Gottlieb. Based on reports from confidential sources, I have previously reported that Dr. Gottlieb also serves the US Central Intelligence Agency as an advisor and was actively engaged with the CIA during the COVIDcrisis. Before first joining the FDA, and in between each of his three tours of government service, Gottlieb was a resident fellow at the American Enterprise Institute. Fortune magazine identified Gottlieb as one of its 2018 “The World’s 50 Greatest Leaders,” ranking him number 6. The magazine stated “Gottlieb has gotten credit for being transparent about FDA steps—and, more important, for using his bully pulpit without being a bully.”

He received his bachelor’s degree in economics from Wesleyan University. After completing his undergraduate education, he worked as a healthcare analyst at the investment bank Alex. Brown & Sons in Baltimore. Gottlieb attended medical school at Icahn School of Medicine at Mount Sinai and completed his residency in internal medicine at the Mount Sinai Hospital.

Advertisement

His ascendency from an otherwise undistinguished internal medicine resident with a background in economics to highly lauded FDA commissioner at age 44 is quite remarkable. Even more remarkable has been his successful strong advocacy and lobbying in corporate media for the CIA to assume a dominant role in public health during the COVIDcrisis – despite never having an official government position involving the CIA, DIA, or other elements of the intelligence community. The depth of his involvement with the agency is unknown, but his advocacy for the interests of the CIA, Pfizer, and the vaccine industry during the time of COVID have been consistent throughout the “pandemic”.

Join the conversation as a VIP Member

Trending on HotAir Videos

Advertisement
Advertisement
Advertisement